A 2025 study reported that among NIH-funded clinical trials whose funding was interrupted, over 36% had been completed, about 35% were recruiting, about 11% were active but not recruiting, about 14% were active but not yet recruiting, and the remaining trials were enrolling by invitation.
August 15, 2025
high
statistical
Status distribution of NIH-funded clinical trials at the time their funding was interrupted in the 2025 study window.